Recombinant human platelet-derived growth factor-BB combined with grafting materials for the treatment of periodontal intrabony defects: a meta-analysis

Wensong Hao; Li  Leilei; Huang Kun; Xiaodong Sui; Yuanyuan Qi

doi:10.2298/VSP241029019H

Wensong Hao Liaocheng University, School of Medicine, Liaocheng, Shandong, China
Leilei Li Dongying People’s Hospital, Dongying, Shandong, China
Kun Huang Liaocheng Traditional Chinese Medicine Hospital, Liaocheng, Shandong, China
Xiaodong Sui Liaocheng Traditional Chinese Medicine Hospital, Liaocheng, Shandong, China
Yuanyuan Qi Dongying People’s Hospital, Dongying, Shandong, China

DOI: https://doi.org/10.2298/VSP241029019H

Keywords: database;, meta-analysis;, periodontal diseases;, platelet-derived growth factor

Abstract

Background/Aim. Periodontitis is a common dental disease affecting around 50% of adult patients globally. It can cause continuous deterioration of periodontal tissue inflammation, leading to irreversible periodontal bone resorption and even tooth loosening. Currently, suitable techniques for managing periodontal intrabony deformities include both allogeneic and autologous bone transplantation, but these methods have certain limitations. The aim of this study was to examine the effect of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in combination with grafting materials for the treatment of periodontal intraosseous defects using a meta-analysis. Methods. In March 2024, electronic databases (Cochrane Library, PubMed, Embase, Web of Science) were searched to gather data from studies on growth factors and grafting materials for the treatment of intrabony periodontal deficiencies. Results. A total of 11 articles were fully reviewed, of which nine were included in the meta-analysis. The 9 studies included 313 people, divided into two groups: experimental (n = 156) and control (n = 157). The results of the meta-analysis indicate significantly higher clinical attachment level (CAL) of the experimental group [p < 0.01, standardized mean difference (SMD): 0.80; 95% confidence interval (CI): 0.49, 1.10] compared to the control group. Changes in probing depth (PD) of the experimental group were greater (p < 0.01, SMD: 0.75; 95% CI: 0.39, 1.11) than in the control group. In addition, bone fill (BF) (p < 0.01, SMD: 22.33; 95% CI: 15.71, 28.95) and linear bone growth (LBG) (p < 0.01, SMD: 0.87; 95% CI: 0.43, 1.30) of the experimental group were greater. The gingival recession (GR) of the experimental group was lower (p < 0.05, SMD: -0.27; 95% CI: -0.51, -0.03) than in the control group. Conclusion. The results indicate that the rhPDGF-BB combined with the grafting material can improve CAL, PD, BF, LBG, and GR in periodontal intrabony defects.

References

Eke PI, Wei L, Borgnakke WS, Thornton-Evans G, Zhang X, Lu H, et al. Periodontitis prevalence in adults ≥ 65 years of age, in the USA. Periodontol 2000 2016; 72(1): 76−95.

Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 2021; 21(7): 426−40.

Loi F, Córdova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB. Inflammation, fracture and bone repair. Bone 2016; 86: 119−30.

Chen MX, Zhong YJ, Dong QQ, Wong HM, Wen YF. Global, re-gional, and national burden of severe periodontitis, 1990-2019: An analysis of the Global Burden of Disease Study 2019. J Clin Periodontol 2021; 48(9): 1165−88.

Tan B, Tang Q, Zhong Y, Wei Y, He L, Wu Y, et al. Biomateri-al-based strategies for maxillofacial tumour therapy and bone defect regeneration. Int J Oral Sci 2021; 13(1): 9.

Zhao R, Yang R, Cooper PR, Khurshid Z, Shavandi A, Ratnayake J. Bone Grafts and Substitutes in Dentistry: A Review of Cur-rent Trends and Developments. Molecules 2021; 26(10): 3007.

Shaikh MS, Zafar MS, Alnazzawi A. Comparing Nanohydroxy-apatite Graft and Other Bone Grafts in the Repair of Perio-dontal Infrabony Lesions: A Systematic Review and Meta-Analysis. Int J Mol Sci 2021; 22(21): 12021.

Solakoğlu Ö, Ofluoğlu D, Schwarzenbach H, Heydecke G, Reißmann D, Ergun S, et al. A 3-year prospective randomized clinical tri-al of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials. Int J Implant Dent 2022; 8(1): 5.

Li Z, Du T, Ruan C, Niu X. Bioinspired mineralized collagen scaffolds for bone tissue engineering. Bioact Mater 2020; 6(5): 1491−511.

Du T, Niu X, Hou S, Xu M, Li Z, Li P, et al. Highly aligned hierarchical intrafibrillar mineralization of collagen induced by periodic fluid shear stress. J Mater Chem B 2020; 8(13): 2562−72.

Fernandez-Yague MA, Abbah SA, McNamara L, Zeugolis DI, Pandit A, Biggs MJ. Biomimetic approaches in bone tissue en-gineering: Integrating biological and physicomechanical strate-gies. Adv Drug Deliv Rev 2015; 84: 1−29.

Buettmann EG, McKenzie JA, Migotsky N, Sykes DA, Hu P, Yoneda S, et al. VEGFA From Early Osteoblast Lineage Cells (Osterix+) Is Required in Mice for Fracture Healing. J Bone Miner Res 2019; 34(9): 1690−706.

Lee J, Lee S, Ahmad T, Madhurakkat Perikamana SK, Lee J, Kim EM, et al. Human adipose-derived stem cell spheroids incor-porating platelet-derived growth factor (PDGF) and bio-minerals for vascularized bone tissue engineering. Biomaterials 2020; 255: 120192.

Ozaki Y, Nishimura M, Sekiya K, Suehiro F, Kanawa M, Nikawa H, et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 2007; 16(1): 119−29.

Jayakumar A, Rajababu P, Rohini S, Butchibabu K, Naveen A, Reddy PK, et al. Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects. J Clin Periodontol 2011; 38(2): 163−72.

Deshpande A, Koudale SB, Bhongade ML. A comparative evalua-tion of rhPDGF-BB + β-TCP and subepithelial connective tissue graft for the treatment of multiple gingival recession de-fects in humans. Int J Periodontics Restorative Dent 2014; 34(2): 241−9.

Maroo S, Murthy KR. Treatment of periodontal intrabony de-fects using β-TCP alone or in combination with rhPDGF-BB: a randomized controlled clinical and radiographic study. Int J Periodontics Restorative Dent 2014; 34(6): 841−7.

Qiao J, Duan J, Zhang Y, Chu Y, Sun C. The effect of concen-trated growth factors in the treatment of periodontal intra-bony defects. Future Sci OA 2016; 2(4): FS136.

Xu Y, Qiu J, Sun Q, Yan S, Wang W, Yang P, et al. One-Year Results Evaluating the Effects of Concentrated Growth fac-tors on the Healing of Intrabony Defects Treated with or without Bone Substitute in Chronic Periodontitis. Med Sci Monit 2019; 25: 4384−9.

Saito A, Bizenjima T, Takeuchi T, Suzuki E, Sato M, Yoshikawa K, et al. Treatment of intrabony periodontal defects using rhFGF-2 in combination with deproteinized bovine bone mineral or rhFGF-2 alone: A 6-month randomized controlled trial. J Clin Periodontol 2019; 46(3): 332−41.

Bahammam MA, Attia MS. Expression of Vascular Endothelial Growth factor Using Platelet Rich Fibrin (PRF) and Nanohy-droxyapatite (nano-HA) in Treatment of Periodontal Intra-Bony Defects – A Randomized Controlled Trial. Saudi J Biol Sci 2021; 28(1): 870−8.

Seshima F, Bizenjima T, Aoki H, Imamura K, Kita D, Irokawa D, et al. Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial. Biomolecules 2022; 12(11): 1682.

Priyanka M, Reddy K, Pradeep K. Efficacy of rh-PDGF-BB and Emdogain with or without DFDBA using M-MIST in the treatment of intrabony defects. Niger J Clin Pract 2023; 26(1): 116−24.

Urist MR. Bone: formation by autoinduction. 1965. Clin Or-thop Relat Res 2002; (395): 4−10.

Um IW, Lee JK, Kim JY, Kim YM, Bakhshalian N, Jeong YK, et al. Allogeneic Dentin Graft: A Review on Its Osteoinductivity and Antigenicity. Materials (Basel) 2021; 14(7): 1713.

Murata M, Kabir MA, Hirose Y, Ochi M, Okubo N, Akazawa T, et al. Histological Evidences of Autograft of Den-tin/Cementum Granules into Unhealed Socket at 5 Months after Tooth Extraction for Implant Placement. J Funct Bio-mater 2022; 13(2): 66.

Grawish ME, Grawish LM, Grawish HM, Grawish MM, Holiel AA, Sultan N, et al. Demineralized Dentin Matrix for Dental and Alveolar Bone Tissues Regeneration: An Innovative Scope Review. Tissue Eng Regen Med 2022; 19(4): 687−701. Erra-tum in: Tissue Eng Regen Med 2022; 19(4): 887−9.

Park DJ, Yoon C, Thomas N, Ku GY, Janjigian YY, Kelsen DP, et al. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gas-troesophageal junction cancers. Ann Surg Oncol 2014; 21(4): 1130−7.

Özveri Koyuncu B, Işık G, Özden Yüce M, Günbay S, Günbay T. Effect of concentrated growth factor (CGF) on short-term clinical outcomes after partially impacted mandibular third molar surgery: A split-mouth randomized clinical study. J Stomatol Oral Maxillofac Surg 2020; 121(2): 118−23.

Yao M, Hu J, Jiang L, Guo R, Wang X. Efficacy of concentrat-ed growth factor combined with grafting materials vs. grafting materials alone for the treatment of periodontal intrabony de-fects: a systematic review and meta-analysis. Ann Transl Med 2023; 11(4): 184.